A retrospective real-world evidence study of STELARA compared to adalimumab in bio-naïve adults with moderately to severely active crohn's disease
Latest Information Update: 28 Oct 2021
At a glance
- Drugs Ustekinumab (Primary) ; Adalimumab
- Indications Crohn's disease
- Focus Therapeutic Use
- 28 Oct 2021 New trial record
- 25 Oct 2021 Results presented in the Janssen Media Release.